Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis (MS) Relapsing Remitting”

250 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 250 results

Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Post-approval studies (Phase 4)UnknownNCT04048577
What this trial is testing

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT04115930
What this trial is testing

Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more
University of Eastern Finland 61
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Not applicableStudy completedNCT00594087
What this trial is testing

Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple SclerosisSleep Initiation and Maintenance DisordersFatigue
University of Vermont 30
Post-approval studies (Phase 4)Study completedNCT01767493
What this trial is testing

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Who this might be right for
Multiple Sclerosis
Institute for Neurodegenerative Disorders 19
Post-approval studies (Phase 4)Study completedNCT01585298
What this trial is testing

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6,998
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Very early researchStudy completedNCT03498131
What this trial is testing

Melatonin in Patients With Multiple Sclerosis (MS).

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Providence Health & Services 30
Large-scale testing (Phase 3)Study completedNCT03093324
What this trial is testing

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 506
Not applicableStudy completedNCT04221191
What this trial is testing

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 353
Not applicableWithdrawnNCT04082468
What this trial is testing

VALIDATE: Factor VIII Trending for MS Relapse

Who this might be right for
Multiple Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix
Testing effectiveness (Phase 2)Study completedNCT00390221
What this trial is testing

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 621
Post-approval studies (Phase 4)Study completedNCT00168766
What this trial is testing

Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Biogen 345
Not applicableStudy completedNCT07346924
What this trial is testing

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Cairo University 60
Not applicableWithdrawnNCT01539395
What this trial is testing

A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MSDx, Inc.
Early research (Phase 1)Study completedNCT01244139
What this trial is testing

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 47
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Load More Results